These U.S. companies are scheduled to report their first quarter earnings for 2014 today. Below is a preview of their key earning metrics, based on consensus estimates of analysts polled by Bloomberg. We have also provided analysts’ consensus buy ratings for these stocks with upside potential for the upcoming 12-months.
-
Hallador Energy Co (NASDAQ: HNRG) processes, mines and sells coal to producers of electric power. The company also owns interests in an oil and gas company with operations in Michigan. HNRG is scheduled to release its first quarter earnings for 2014 today (May 15, 2014).
As per analysts’ consensus estimates polled by Bloomberg, first quarter net sales for HNRG are estimated to decline 5% to $35.80 million over the previous year quarter, while the net income is seen declining to $3.50 million or 12 cents per share from $5.47 million or 19 cents/share recorded during the first quarter of 2013. The EBITDA during the quarter is seen improving by 23% to 10.5 million year-over-year.
Total Analyst Coverage
4
Buy Ratings
100%
Upside Potential
25.5%
-
First Financial Service Corporation (NASDAQ: FFKY) is the holding company for First Federal Savings Bank. The bank primarily attracts deposits from the general public and originates mortgage loans on single-family residences and commercial properties in the central Kentucky area. FFKY will release its first quarter earnings for 2014 today (May 15, 2014).
As per analysts’ consensus estimates polled by Bloomberg, first quarter revenues for FFKY are seen at 7.70 million, up 4% over the same quarter last year. However, net losses are estimated to widen to 0.30 million or 15 cents per share from the earlier losses of 0.14 million or 3 cents per share.
Total Analyst Coverage
2
Hold Ratings
50%
Upside Potential
-2.8%
-
Catalyst Pharmaceutical Partners Inc (NASDAQ: CPRX), is a pharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction. The company develops drugs for addictions such as methamphetamine, nicotine, prescription pain medications, alcohol, and marijuana, as well as treatments for related addictive disorders, such as obesity and gambling. CPRX will release its first quarter earnings for 2014 today (May 15, 2014).
As per analysts’ consensus estimates polled by Bloomberg, net losses for CPRX are estimated to increase to 3.61 million from the earlier losses of 1.74 million during the first quarter of 2014. Loss per share is seen at 7 cents during the quarter.
Total Analyst Coverage
5
Buy Ratings
100%
Upside Potential
157.1%
